Istvan Petak: How AI is advancing our fight against cancer
Istvan Petak shared on Linkedin:
”Hello Amazing Budapest, Hello Amazing AI Summit Budapest!
AI is transforming all aspects of our lives. It was my privilege to give a keynote presentation on how AI is advancing our fight against cancer. I also had the opportunity to deliver some of the primary critical messages of the CancerX Moonshot Summit in Washington from the previous week.
Our mission at Genomate Health is to find the right targeted therapy for cancer patients based on their tumor’s molecular profile wherever they live. AI must also decrease inequality in healthcare. All cancer patients should have access to the best available therapies.”
Source: Istvan Petak/Linkedin
Dr. Istvan Petak specialises in precision oncology and molecular pharmacology of targeted therapies. He is the founder and CEO of Genomate Health, Inc. Cambridge, MA, founder and board director of Oncompass Medicine, Budapest, HU, and adjunct professor at the Department of Pharmaceutical Sciences at the University of Illinois at Chicago (UIC).
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023